Company
A TechBio company that would rather be checked than believed.
Cellazon Inc. builds PathwayPersona™ and the platform that runs it. We work with pharma, biotech, and academic partners on questions where knowing which cells are talking changes the decision.
How we work
Claim less, show more
We would rather under-describe the platform on a public page and over-deliver in a technical session than the reverse.
Confidentiality is operational
Partner protocols, patient data, and internal specifications stay inside the boundary they were shared within. Nothing sensitive is published, indexed, or used as marketing material.
Small team, sharp scope
We build custom software only where it differentiates the science, and adopt proven infrastructure everywhere else.
Who we work with
Three ways engagements usually start.
- Pharma and biotech
- Target and biomarker discovery on your cohort, scoped around a specific clinical question and a prespecified validation plan.
- Academic collaborators
- Joint analyses where the science is publishable and the methodology is stated in full.
- Investors
- Technical diligence sessions covering methodology, differentiation, and platform roadmap under NDA.
Data handling
Consent, access control, and provenance are part of the build.
Patient-derived data carries obligations that do not disappear because the analysis is computational. Access is scoped, actions are traceable, and results are reproducible from recorded inputs. Where a partner imposes stricter terms, those terms govern.
Get in touch
Tell us the question you are trying to answer and we will tell you whether we are the right team for it.
Contact Cellazon